This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n14http://linked.opendata.cz/resource/drugbank/drug/DB07838/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07838/identifier/pdb/
n8http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07838/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07838/identifier/pubchem-substance/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07838/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07838
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB07838 n10:DB07838
dcterms:title
(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE
adms:identifier
n4:DB07838 n11:GN8 n12:99444309 n13:5726921 n14:4661060
n5:IUPAC-Name
n6:271B441A-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4420-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B441F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B441C-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B441D-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B441E-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4418-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4419-363D-11E5-9242-09173F13E4C5 n6:271B4416-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4417-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4426-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4427-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4421-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4422-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4424-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4423-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4425-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B442C-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B442E-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B442F-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B442B-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B442A-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B442D-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B441B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4428-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4429-363D-11E5-9242-09173F13E4C5